Hims & Hers Health Inc is a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals, enabling them to access high-quality medical care for numerous conditions ...

In the latest trading session, Hims & Hers Health, Inc. (HIMS) closed at $34.71, marking a +0.7% move from the previous day.

RKLX, the Defiance Daily Target 2X Long RKLB ETF, seeks daily investment results that correspond to twice (200%) the daily percentage change of Rocket Lab, a company at the forefront of satellite ...

Believe it or not, there's something worse than male pattern baldness. It's depression, plunging libido and shrinking ...

Meet 10 trailblazing Black women breaking barriers and driving change across sports, business, healthcare, and leadership.

Changes are afoot in the teledermatology space. As Hims & Hers shutters Apostrophe, the teledermatology specialist it ...

Define Ventures, one of the largest venture capital firms focused on early-stage health tech companies, today announced that ...

In an increasingly competitive telehealth weight loss market, thoughtful and transparent branding is critical.

Walgreens is selling itself to the private equity firm Sycamore Partners. This comes after the company has faced increased ...

Apostrophe, a Bay Area telehealth company focused on skin care, shut down after almost four years under the Hims & Hers ...

Hims & Hers Health will shut down Apostrophe, its personalized acne treatments dermatology business, the company said on Friday. Apostrophe is being shut down to “simplify its (company’s) dermatology ...